Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dolby Laboratories (DLB) Asset Writedowns and Impairment (2016 - 2025)

Historic Asset Writedowns and Impairment for Dolby Laboratories (DLB) over the last 17 years, with Q4 2025 value amounting to $792000.0.

  • Dolby Laboratories' Asset Writedowns and Impairment rose 849.32% to $792000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $2.5 million, marking a year-over-year increase of 33408.7%. This contributed to the annual value of $2.4 million for FY2025, which is 20789.01% up from last year.
  • As of Q4 2025, Dolby Laboratories' Asset Writedowns and Impairment stood at $792000.0, which was up 849.32% from -$148000.0 recorded in Q3 2025.
  • In the past 5 years, Dolby Laboratories' Asset Writedowns and Impairment ranged from a high of $16.6 million in Q3 2023 and a low of -$2.3 million during Q3 2021
  • Moreover, its 5-year median value for Asset Writedowns and Impairment was $631000.0 (2024), whereas its average is $1.1 million.
  • The largest annual percentage gain for Dolby Laboratories' Asset Writedowns and Impairment in the last 5 years was 113233.53% (2023), contrasted with its biggest fall of 23462.53% (2023).
  • Dolby Laboratories' Asset Writedowns and Impairment (Quarter) stood at $1.6 million in 2021, then tumbled by 166.07% to -$1.0 million in 2022, then crashed by 103.98% to -$2.1 million in 2023, then soared by 134.75% to $730000.0 in 2024, then grew by 8.49% to $792000.0 in 2025.
  • Its Asset Writedowns and Impairment was $792000.0 in Q4 2025, compared to -$148000.0 in Q3 2025 and $615000.0 in Q2 2025.